Cargando…

Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study

BACKGROUND: To examine whether lower insulin sensitivity as determined by homeostatic model assessment (HOMA-%S) was associated with increased left ventricular mass (LVM) and presence of LV diastolic dysfunction at long-term follow-up, independently of body mass index (BMI), in middle-aged, otherwis...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Mette Lundgren, Pareek, Manan, Gerke, Oke, Leósdóttir, Margrét, Nilsson, Peter M., Olsen, Michael Hecht
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676144/
https://www.ncbi.nlm.nih.gov/pubmed/26655187
http://dx.doi.org/10.1186/s12872-015-0165-3
_version_ 1782405120936378368
author Nielsen, Mette Lundgren
Pareek, Manan
Gerke, Oke
Leósdóttir, Margrét
Nilsson, Peter M.
Olsen, Michael Hecht
author_facet Nielsen, Mette Lundgren
Pareek, Manan
Gerke, Oke
Leósdóttir, Margrét
Nilsson, Peter M.
Olsen, Michael Hecht
author_sort Nielsen, Mette Lundgren
collection PubMed
description BACKGROUND: To examine whether lower insulin sensitivity as determined by homeostatic model assessment (HOMA-%S) was associated with increased left ventricular mass (LVM) and presence of LV diastolic dysfunction at long-term follow-up, independently of body mass index (BMI), in middle-aged, otherwise healthy males. METHODS: Prospective population-based cohort study with a median (IQR) follow-up time of 28 (27–28) years, in which traditional cardiovascular risk factors, including HOMA-%S and BMI, were assessed at baseline, and echocardiographic determination of LVM and LV diastolic function was performed at follow-up. Associations between risk factors and echocardiographic variables were tested using multivariable linear and binary logistic regression. RESULTS: The study population comprised 247 men with a median (IQR) age of 47 (47–48) years. Mean (SD) BMI was 25.1 +/− 3.0 kg/m(2), and median (IQR) HOMA-%S was 113.0 (68.3–284.6). Subjects with low insulin sensitivity (lowest HOMA-%S quartile (Q1)) had significantly greater BMI, fasting plasma insulin, and higher fasting blood glucose (FBG) (p <0.02 for all). BMI and HOMA-%S were significantly correlated (r = −0.383, p <0.0001). At follow-up, mean (SD) LVM and LVMI were 202 +/− 61 g and 103 +/− 31 g/m(2), respectively, whereas median (IQR) E/é was 10 (8–12). Moreover, 36 % had grade 2 or 3 diastolic dysfunction. In multivariable analyses, greater BMI, but not low insulin sensitivity was independently associated with later detection of increased LVM and diastolic dysfunction. CONCLUSION: Greater baseline BMI, but not lower insulin sensitivity was independently associated with greater LVM and diastolic dysfunction at long-term follow-up. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12872-015-0165-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4676144
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46761442015-12-12 Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study Nielsen, Mette Lundgren Pareek, Manan Gerke, Oke Leósdóttir, Margrét Nilsson, Peter M. Olsen, Michael Hecht BMC Cardiovasc Disord Research Article BACKGROUND: To examine whether lower insulin sensitivity as determined by homeostatic model assessment (HOMA-%S) was associated with increased left ventricular mass (LVM) and presence of LV diastolic dysfunction at long-term follow-up, independently of body mass index (BMI), in middle-aged, otherwise healthy males. METHODS: Prospective population-based cohort study with a median (IQR) follow-up time of 28 (27–28) years, in which traditional cardiovascular risk factors, including HOMA-%S and BMI, were assessed at baseline, and echocardiographic determination of LVM and LV diastolic function was performed at follow-up. Associations between risk factors and echocardiographic variables were tested using multivariable linear and binary logistic regression. RESULTS: The study population comprised 247 men with a median (IQR) age of 47 (47–48) years. Mean (SD) BMI was 25.1 +/− 3.0 kg/m(2), and median (IQR) HOMA-%S was 113.0 (68.3–284.6). Subjects with low insulin sensitivity (lowest HOMA-%S quartile (Q1)) had significantly greater BMI, fasting plasma insulin, and higher fasting blood glucose (FBG) (p <0.02 for all). BMI and HOMA-%S were significantly correlated (r = −0.383, p <0.0001). At follow-up, mean (SD) LVM and LVMI were 202 +/− 61 g and 103 +/− 31 g/m(2), respectively, whereas median (IQR) E/é was 10 (8–12). Moreover, 36 % had grade 2 or 3 diastolic dysfunction. In multivariable analyses, greater BMI, but not low insulin sensitivity was independently associated with later detection of increased LVM and diastolic dysfunction. CONCLUSION: Greater baseline BMI, but not lower insulin sensitivity was independently associated with greater LVM and diastolic dysfunction at long-term follow-up. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12872-015-0165-3) contains supplementary material, which is available to authorized users. BioMed Central 2015-12-10 /pmc/articles/PMC4676144/ /pubmed/26655187 http://dx.doi.org/10.1186/s12872-015-0165-3 Text en © Nielsen et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Nielsen, Mette Lundgren
Pareek, Manan
Gerke, Oke
Leósdóttir, Margrét
Nilsson, Peter M.
Olsen, Michael Hecht
Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study
title Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study
title_full Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study
title_fullStr Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study
title_full_unstemmed Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study
title_short Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study
title_sort greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676144/
https://www.ncbi.nlm.nih.gov/pubmed/26655187
http://dx.doi.org/10.1186/s12872-015-0165-3
work_keys_str_mv AT nielsenmettelundgren greaterbodymassindexisabetterpredictorofsubclinicalcardiacdamageatlongtermfollowupinmenthanisinsulinsensitivityaprospectivepopulationbasedcohortstudy
AT pareekmanan greaterbodymassindexisabetterpredictorofsubclinicalcardiacdamageatlongtermfollowupinmenthanisinsulinsensitivityaprospectivepopulationbasedcohortstudy
AT gerkeoke greaterbodymassindexisabetterpredictorofsubclinicalcardiacdamageatlongtermfollowupinmenthanisinsulinsensitivityaprospectivepopulationbasedcohortstudy
AT leosdottirmargret greaterbodymassindexisabetterpredictorofsubclinicalcardiacdamageatlongtermfollowupinmenthanisinsulinsensitivityaprospectivepopulationbasedcohortstudy
AT nilssonpeterm greaterbodymassindexisabetterpredictorofsubclinicalcardiacdamageatlongtermfollowupinmenthanisinsulinsensitivityaprospectivepopulationbasedcohortstudy
AT olsenmichaelhecht greaterbodymassindexisabetterpredictorofsubclinicalcardiacdamageatlongtermfollowupinmenthanisinsulinsensitivityaprospectivepopulationbasedcohortstudy